OCA at 06:15, 22 August 2018

OCA — Wed, 22 Aug 2018 06:15:57 GMT

←Older revision		Revision as of 06:15, 22 August 2018
Line 1:		Line 1:
-	'''Unreleased structure'''

-	~~The entry~~ 6fxm is ~~ON HOLD until Paper~~ Publication	+	==Crystal Structure of full-length Human Lysyl Hydroxylase LH3 - Cocrystal with Mn2+==
		+	<StructureSection load='6fxm' size='340' side='right' caption='[[6fxm]], [[Resolution\|resolution]] 2.10Å' scene=''>
		+	== Structural highlights ==
		+	<table><tr><td colspan='2'>[[6fxm]] is a 1 chain structure. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=6FXM OCA]. For a <b>guided tour on the structure components</b> use [http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=6FXM FirstGlance]. <br>
		+	</td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand\|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=AKG:2-OXOGLUTARIC+ACID'>AKG</scene>, <scene name='pdbligand=FE2:FE+(II)+ION'>FE2</scene>, <scene name='pdbligand=GOL:GLYCEROL'>GOL</scene>, <scene name='pdbligand=MN:MANGANESE+(II)+ION'>MN</scene>, <scene name='pdbligand=NAG:N-ACETYL-D-GLUCOSAMINE'>NAG</scene></td></tr>
		+	<tr id='activity'><td class="sblockLbl"><b>Activity:</b></td><td class="sblockDat"><span class='plainlinks'>[http://en.wikipedia.org/wiki/Oxidoreductase Oxidoreductase], with EC number [http://www.brenda-enzymes.info/php/result_flat.php4?ecno=1.14.11.4 1.14.11.4] </span></td></tr>
		+	<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=6fxm FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=6fxm OCA], [http://pdbe.org/6fxm PDBe], [http://www.rcsb.org/pdb/explore.do?structureId=6fxm RCSB], [http://www.ebi.ac.uk/pdbsum/6fxm PDBsum], [http://prosat.h-its.org/prosat/prosatexe?pdbcode=6fxm ProSAT]</span></td></tr>
		+	</table>
		+	== Disease ==
		+	[[http://www.uniprot.org/uniprot/PLOD3_HUMAN PLOD3_HUMAN]] Connective tissue disorder due to lysyl hydroxylase-3 deficiency. The disease is caused by mutations affecting the gene represented in this entry.
		+	== Function ==
		+	[[http://www.uniprot.org/uniprot/PLOD3_HUMAN PLOD3_HUMAN]] Forms hydroxylysine residues in -Xaa-Lys-Gly- sequences in collagens. These hydroxylysines serve as sites of attachment for carbohydrate units and are essential for the stability of the intermolecular collagen cross-links.[UniProtKB:P24802]
		+	<div style="background-color:#fffaf0;">
		+	== Publication Abstract from PubMed ==
		+	Lysyl hydroxylases catalyze hydroxylation of collagen lysines, and sustain essential roles in extracellular matrix (ECM) maturation and remodeling. Malfunctions in these enzymes cause severe connective tissue disorders. Human lysyl hydroxylase 3 (LH3/PLOD3) bears multiple enzymatic activities, as it catalyzes collagen lysine hydroxylation and also their subsequent glycosylation. Our understanding of LH3 functions is currently hampered by lack of molecular structure information. Here, we present high resolution crystal structures of full-length human LH3 in complex with cofactors and donor substrates. The elongated homodimeric LH3 architecture shows two distinct catalytic sites at the N- and C-terminal boundaries of each monomer, separated by an accessory domain. The glycosyltransferase domain displays distinguishing features compared to other known glycosyltransferases. Known disease-related mutations map in close proximity to the catalytic sites. Collectively, our results provide a structural framework characterizing the multiple functions of LH3, and the molecular mechanisms of collagen-related diseases involving human lysyl hydroxylases.

-	~~Authors~~:	+	Molecular architecture of the multifunctional collagen lysyl hydroxylase and glycosyltransferase LH3.,Scietti L, Chiapparino A, De Giorgi F, Fumagalli M, Khoriauli L, Nergadze S, Basu S, Olieric V, Cucca L, Banushi B, Profumo A, Giulotto E, Gissen P, Forneris F Nat Commun. 2018 Aug 8;9(1):3163. doi: 10.1038/s41467-018-05631-5. PMID:30089812<ref>PMID:30089812</ref>

-	~~Description~~:	+	From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.<br>
-	[[Category: ~~Unreleased Structures~~]]	+	</div>
		+	<div class="pdbe-citations 6fxm" style="background-color:#fffaf0;"></div>
		+	== References ==
		+	<references/>
		+	__TOC__
		+	</StructureSection>
		+	[[Category: Oxidoreductase]]
		+	[[Category: Banushi, B]]
		+	[[Category: Basu, S]]
		+	[[Category: Chiapparino, A]]
		+	[[Category: Forneris, F]]
		+	[[Category: Fumagalli, M]]
		+	[[Category: Giorgi, F De]]
		+	[[Category: Gissen, P]]
		+	[[Category: Giulotto, E]]
		+	[[Category: Khoriauli, L]]
		+	[[Category: Nergadze, S]]
		+	[[Category: Olieric, V]]
		+	[[Category: Scietti, L]]
		+	[[Category: Collagen]]
		+	[[Category: Galacosyltransferase]]
		+	[[Category: Glucosyltransferase]]
		+	[[Category: Lysyl hydroxylase]]
		+	[[Category: Transferase]]

OCA: Protected "6fxm" [edit=sysop:move=sysop]

OCA — Wed, 21 Mar 2018 06:19:07 GMT

Protected "6fxm" [edit=sysop:move=sysop]

←Older revision

Revision as of 06:19, 21 March 2018

OCA: New page: '''Unreleased structure''' The entry 6fxm is ON HOLD until Paper Publication Authors: Description: Category: Unreleased Structures

OCA — Wed, 21 Mar 2018 06:19:06 GMT

New page: '''Unreleased structure''' The entry 6fxm is ON HOLD until Paper Publication Authors: Description: Category: Unreleased Structures

New page

'''Unreleased structure'''

The entry 6fxm is ON HOLD until Paper Publication

Authors:

Description:
[[Category: Unreleased Structures]]

6fxm - Revision history

OCA at 06:15, 22 August 2018

OCA: Protected "6fxm" [edit=sysop:move=sysop]

OCA: New page: '''Unreleased structure''' The entry 6fxm is ON HOLD until Paper Publication Authors: Description: Category: Unreleased Structures